about
Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.Overview of drug product development.Analytical methods and formulation factors to enhance protein stability in solution.Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerDevelopment of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Lack of a synergistic effect of arginine-glutamic acid on the physical stability of spray-dried bovine serum albumin.Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.
P2860
Q36111924-91240FCA-F580-4A08-B7FE-1DA4A398A498Q37579215-B6E6F403-FB89-4941-A5CD-4A01683FB489Q37965423-578375AC-1E10-4B7A-8FA7-9DC9E2594AB6Q38065104-C7A86188-3CB1-4BAB-8C98-C5CA602C5C14Q38268308-F936FBDC-EB22-46C0-9D16-251CE091582AQ38678186-362DF7C1-FAAF-4434-B227-B1543A3071B4Q38865450-5B362EF6-B790-4592-8B89-46EFC87003ABQ42588809-0C809B47-B999-4A6D-8EDE-61D80A636853
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
type
label
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
prefLabel
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
P1476
The formulation of biopharmaceutical products.
@en
P2093
Lashmar UT
Parkins DA
P304
P356
10.1016/S1461-5347(00)00248-0
P577
2000-04-01T00:00:00Z